This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

IRIDEX Announces Automatic Conversion Of Series A Preferred Stock To Common Stock

MOUNTAIN VIEW, Calif., June 11, 2013 /PRNewswire/ --  IRIDEX Corporation (Nasdaq: IRIX) today announced that it has converted all outstanding shares of its Series A Preferred Stock into 1,000,000 shares of its common stock. The Series A Preferred shares were issued to BlueLine Capital Partners LP (BlueLine) as part of a private placement agreement that occurred in 2007. The Certificate of Designation provides that the Series A Preferred shares will automatically convert into common stock if IRIDEX common stock trades above $5.00 for 30 consecutive trading days.

"This is a positive development for the Company and has been a goal since BlueLine invested in IRIDEX in a private placement and the preferred shares were issued in 2007," Will Moore President and CEO of IRIDEX said. "I want to thank BlueLine for their initial and ongoing support that has allowed us to get to this point. The conversion simplifies our capital structure, is non-dilutive and is an indication that we have made great strides in the past year in meeting commercial and operational milestones and winning investor confidence. The Series A Preferred Stock has always been included in the diluted share count and will be part of the basic and diluted share count going forward."

As a result of the conversion, the separate right of the holders of Series A Preferred Stock to a senior liquidation preference and to appoint a second board member, subject to the approval of the Company, have also ceased.


IRIDEX Corporation was founded in 1989 and is a worldwide leader in developing, manufacturing, and marketing innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology market. We maintain a deep commitment to the success of our customers, with comprehensive technical, clinical, and service support programs. IRIDEX is dedicated to a standard of excellence, offering superior technology for superior results. IRIDEX products are sold in the United States through a direct sales force and internationally through a combination of a direct sales force and a network of approximately 70 independent distributors into over 100 countries. For further information, visit the IRIDEX website at

Safe Harbor Statement

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,741.17 -57.32 -0.32%
S&P 500 2,084.04 -6.07 -0.29%
NASDAQ 5,113.46 -14.0650 -0.27%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs